logo
Select company
Select metric
3.97Price to Sales
VS
Market
31
Sector
49
Industry
73
History
81
$ 3.11Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - Price to Sales Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - P/S Historical data
DateMarket CapitalizationPrice to SalesRevenues
6/30/2025$ 16.69M3.97$ 4.21M
3/31/2025$ 17.3M4.71$ 3.67M
12/31/2024$ 17.66M1.58$ 11.2M
9/30/2024$ 29.89M3.77$ 7.92M
6/30/2024$ 23.48M4.89$ 4.8M
3/31/2024$ 28.02M5.95$ 4.71M
12/31/2023$ 19.3M0$ -2.85M
9/30/2023$ 13.24M0$ -3.07M
6/30/2023$ 26.63M484.31$ 54.99K
3/31/2023$ 25.23M45.45$ 554.99K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) P/S stands at 0.
  • Over the past 5 years, LIPOCINE INC's average P/S has been 178.99.
  • The median P/S for LIPOCINE INC during this period was 4.8
  • LIPOCINE INC reached its highest P/S over the past 5 years at 1.88K.
  • The lowest P/S recorded by LIPOCINE INC in the same timeframe 1.58

LIPOCINE INC's P/S vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/S Benchmarks
CompanyP/S
MRKR : MARKER THERAPEUTICS INC 3BOLT : BOLT BIOTHERAPEUTICS INC 2.51TRAW : TRAWS PHARMA INC 3.94NRXS : NEURAXIS INC 7.63LGVN : LONGEVERON INC 6.3XAIR : BEYOND AIR INC 3.45DYAI : DYADIC INTERNATIONAL INC 7.18INM : INMED PHARMACEUTICALS INC 1.03LEXX : LEXARIA BIOSCIENCE CORP 26.48INBS : INTELLIGENT BIO SOLUTIONS INC 3.41

Definition of Price to Sales

[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Market Cap / Revenues
(=) P/S
P/S for LIPOCINE INC is calculated as follows: Market Cap [ $ 91.96M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ]

LPCN - Price to Sales, Last 5 years

1.58

Minimum

Dec 31, 2024

1.88K

Maximum

Sep 30, 2021

178.99

Average

4.8

Median

P/S Benchmark Analysis

The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
filtered constituents3.41K
min0
max11.15
average2.62
median1.97
std2.38